Tracking efforts to advance the mission and concept of “clinical research as a care option.”
Related Posts
Phase III Trials Confirm Remibrutinib Effectively Reduces Chronic Spontaneous Urticaria Symptoms
Credit: ABUL | stock.adobe.com Findings from the Phase III REMIX-1 (NCT05030311) and REMIX-2 (NCT05032157) clinical trials show that remibrutinib reduces…
Two Year Trial Data Show Long-Term Efficacy of Izervay for Geographic Atrophy Secondary to Age-Related Macular Degeneration
Image credit: RFBSIP | stock.adobe.com Astellas Pharma Inc. has filed a supplemental New Drug Application (sNDA) with the FDA to…
IDEAYA Shares Positive Phase II Data for Darovasertib and Plans for Future Phase III Trial
Image Credit: © Christoph Burgstedt – stock.adobe.com IDEAYA Biosciences has shared positive interim Phase II data for darovasertib in neoadjuvant…